LMAT - LeMaitre Vascular, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
39.1384
+0.7634 (+1.9893%)
As of 11:47AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close38.3750
Open38.6500
Bid39.1000 x 500
Ask39.1500 x 200
Day's Range38.6320 - 39.6000
52 Week Range18.5500 - 39.6000
Volume122,005
Avg. Volume188,504
Market Cap744.53M
Beta0.66
PE Ratio (TTM)55.91
EPS (TTM)0.7
Earnings DateOct 24, 2017 - Oct 30, 2017
Forward Dividend & Yield0.22 (0.59%)
Ex-Dividend Date2017-08-21
1y Target Est32.71
Trade prices are not sourced from all markets
  • GlobeNewswire4 days ago

    LeMaitre Vascular Will Announce Third Quarter 2017 Earnings Results on October 26, 2017

    BURLINGTON, Mass., Oct. 16, 2017-- LeMaitre Vascular, Inc. announced today that it will release its third quarter 2017 financial results on Thursday, October 26, 2017, after the market close. The company ...

  • Capital Cube22 days ago

    ETFs with exposure to LeMaitre Vascular, Inc. : September 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to LeMaitre Vascular, Inc. Here are 5 ETFs with the largest exposure to LMAT-US. Comparing the performance and risk of LeMaitre Vascular, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Stocks With Rising Relative Strength: Penumbra
    Investor's Business Daily23 days ago

    Stocks With Rising Relative Strength: Penumbra

    A Relative Strength Rating upgrade for Penumbra shows improving technical performance. Will it continue?

  • 5 MedTech Stocks to Pick for Stellar Returns
    Zackslast month

    5 MedTech Stocks to Pick for Stellar Returns

    While the MedTech industry has been grappling with multiple issues, these stocks with high growth potential can be great bets.

  • 3 Dividend Healthcare Stocks
    Motley Foollast month

    3 Dividend Healthcare Stocks

    Looking for income from the healthcare sector? Here's why you should check out Gilead Sciences, Allergan, and LeMaitre Vascular.

  • Capital Cubelast month

    ETFs with exposure to LeMaitre Vascular, Inc. : September 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to LeMaitre Vascular, Inc. Here are 5 ETFs with the largest exposure to LMAT-US. Comparing the performance and risk of LeMaitre Vascular, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017
    Capital Cubelast month

    LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017

    Categories: Yahoo FinanceGet free summary analysis LeMaitre Vascular, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of LeMaitre Vascular, Inc. – Endologix, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Cardiovascular Systems, Inc., C. R. Bard, Inc., Baxter International Inc. and Teleflex Incorporated (ELGX-US, BSX-US, EW-US, ... Read more (Read more...)

  • 5 Top-Ranked MedTech Growth Stocks for Solid Returns
    Zackslast month

    5 Top-Ranked MedTech Growth Stocks for Solid Returns

    Despite the ongoing turmoil in the MedTech industry, these stocks with high growth potential can be great bets for investors.

  • Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead
    Zackslast month

    Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead

    The share price performance of Abbott Laboratories (ABT) has been disappointing over the last three years. Of the prime issues plaguing Abbott, foreign exchange is a major one.

  • GlobeNewswirelast month

    LeMaitre Vascular to Present at Upcoming Investor Conferences

    BURLINGTON, Mass., Sept. 05, 2017-- LeMaitre Vascular, Inc. announced today that it will be participating in three investor conferences.. JJ Pellegrino, Chief Financial Officer, is scheduled to present ...

  • Why LeMaitre Vascular (LMAT) Could Be Positioned for a Surge
    Zacks2 months ago

    Why LeMaitre Vascular (LMAT) Could Be Positioned for a Surge

    LeMaitre Vascular (LMAT) is seeing solid earnings estimate revisions, and the stock is showing decent short-term momentum as well.

  • Capital Cube2 months ago

    LeMaitre Vascular, Inc. – Value Analysis (NASDAQ:LMAT) : August 14, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives LeMaitre Vascular, Inc. a score of 81. Our analysis is based on comparing LeMaitre Vascular, Inc. with the following peers – AngioDynamics, Inc., Endologix, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Cardiovascular Systems, Inc., C. R. Bard, Inc., Baxter International Inc. and Teleflex Incorporated (ANGO-US, ELGX-US, BSX-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of LMAT earnings conference call or presentation 27-Jul-17 9:00pm GMT

    Q2 2017 LeMaitre Vascular Inc Earnings Call

  • Forbes3 months ago

    Heart-Felt Buys: 6 Cardiac Opportunities

    Six biotech companies developing treatment and monitoring of heart disease are investing ideas that five advisors highlight.

  • GlobeNewswire3 months ago

    LeMaitre Vascular to Present at Upcoming Investor Conferences

    BURLINGTON, Mass., Aug. 01, 2017-- LeMaitre Vascular, Inc. announced today that it will be participating in two investor conferences.. JJ Pellegrino, Chief Financial Officer, will participate in the Needham ...

  • LeMaitre Vascular, Inc.: Leads amongst peers with strong fundamentals
    Capital Cube3 months ago

    LeMaitre Vascular, Inc.: Leads amongst peers with strong fundamentals

    Categories: Yahoo FinanceLeMaitre Vascular, Inc. relative valuation is OVERVALUED and it has a fundamental analysis score of 88. Our analysis is based on comparing LeMaitre Vascular, Inc. with the following peers – AngioDynamics, Inc., Endologix, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Cardiovascular Systems, Inc., C. R. Bard, Inc., Baxter International Inc. and Teleflex Incorporated (ANGO-US, ELGX-US, ... Read more (Read more...)

  • Top Ranked Momentum Stocks to Buy for July 31st
    Zacks3 months ago

    Top Ranked Momentum Stocks to Buy for July 31st

    Top Ranked Momentum Stocks to Buy for July 31st

  • LeMaitre Vascular, Inc. breached its 50 day moving average in a Bullish Manner : LMAT-US : July 31, 2017
    Capital Cube3 months ago

    LeMaitre Vascular, Inc. breached its 50 day moving average in a Bullish Manner : LMAT-US : July 31, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for LeMaitre Vascular, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • LeMaitre Vascular (LMAT) Worth a Look: Stock Jumps 19.5%
    Zacks3 months ago

    LeMaitre Vascular (LMAT) Worth a Look: Stock Jumps 19.5%

    LeMaitre Vascular, Inc. (LMAT) shares jumped above 19% in the last trading session.

  • Associated Press3 months ago

    LeMaitre tops Street 2Q forecasts

    On a per-share basis, the Burlington, Massachusetts-based company said it had net income of 23 cents. The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks ...

  • GlobeNewswire3 months ago

    LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%)

    BURLINGTON, Mass., July 27, 2017-- LeMaitre Vascular, Inc., a provider of vascular devices, implants and services, today reported Q2 2017 results, provided increased guidance, announced a $0.055/ share ...

  • ACCESSWIRE3 months ago

    Investor Network: LeMaitre Vascular, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / July 27, 2017 / LeMaitre Vascular, Inc. (NASDAQ: LMAT ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, July 27, 2017 at 5:00 PM ...

  • 3 Under-the-Radar Stocks in the Healthcare Sector
    Motley Fool3 months ago

    3 Under-the-Radar Stocks in the Healthcare Sector

    Syndax Pharmaceuticals, Corcept Therapeutics, and LeMaitre Vascular might not be household names, but they are companies investors should get to know.

  • Capital Cube3 months ago

    ETFs with exposure to LeMaitre Vascular, Inc. : July 24, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to LeMaitre Vascular, Inc. Here are 5 ETFs with the largest exposure to LMAT-US. Comparing the performance and risk of LeMaitre Vascular, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)